Autres langues Amarin Corporation plc

Actions

AMRN

US0231114044

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 25/09/2026			Varia. 5j.	Varia. 1 janv.
13,20 ^USD	-1,71%		-3,15%	-5,41%

25/09	Les actions européennes négociées aux États-Unis sous forme de certificats américains de dépôt (ADR) progressent légèrement vendredi, mais reculent sur la semaine	MT
10/09	Les actions européennes cotées aux États-Unis sous forme d'ADR en repli lors de la séance de jeudi	MT

Autres langues

25/09	European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading; Down for Week
10/09	European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading
08/09	Amarin, Kruengkao Form JV to Expand Entertainment Business
01/09	European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading
31/08	Amarin Highlights New Reduce-It and Mechanistic Data At European Society of Cardiology Congress
31/08	Amarin - New REDUCE-IT Legacy Analysis Presented at European Society of Cardiology Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
31/08	Amarin Highlights New REDUCE-IT® and Mechanistic Data Presented at European Society of Cardiology (ESC) Congress 2026
28/08	New REDUCE-IT® Legacy Analysis Presented at European Society of Cardiology (ESC) Congress 2026 Suggests Persistent Cardiovascular Benefit Following Icosapent Ethyl Treatment Cessation in Adherent Patients
26/08	European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
24/08	New Analyses from REDUCE-IT® and EPA Mechanistic Data to be Presented at the European Society of Cardiology (ESC) Congress 2026
12/08	European Equities Traded in the US as American Depositary Receipts Edge Lower in Wednesday Trading
29/07	Tranche Update on Amarin Corporation plc's Equity Buyback Plan announced on May 1, 2024.
29/07	European Equities Traded in US as ADRs Ease in Wednesday Trading
29/07	Amarin Corporation plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
29/07	Amarin: Q2 Earnings Snapshot
29/07	Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
15/07	Amarin to Report Second Quarter 2026 Financial Results and Host Conference Call on July 29, 2026
02/07	European Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading
30/06	Amarin Reaffirms the Proven, Guideline-Recommended Role of VASCEPA® (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
30/06	Amarin Corporation plc Reaffirms the Proven Guideline-Recommended Role of Vascepa (Icosapent Ethyl) in an Evolving Triglyceride Treatment Landscape
29/06	European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading
23/06	Top cases on the US Supreme Court's docket
22/06	European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
18/06	European Equities Traded in the US as American Depositary Receipts Little Changed in Thursday Trading
09/06	European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading